Abstract
G-protein coupled receptors (GPCRs) are the largest single family of signaling molecules in mammals and represent approximately 2-3% of all genes in the human genome. Estimates of the total number of GPCR genes in the human genome range from about 750 to 1000. GPCRs mediate signaling by a wide variety of ligands including amino acids, ions, biogenic amines, peptides, glycoproteins, light, pheromones, and odorants. There are presently only a handful of GPCRs whose structures have been elucidated. Of these, the mGluR1 subtype of metabotropic glutamate receptor (mGluR) and rhodopsin are the most widely used in modeling GPCRs. In the case of mGluR1, the three-dimensional structure of the extracellular ligand binding domain of the molecule has been solved, while the crystallographic data for rhodopsin encompasses the whole protein in the ground state with bound 11-cis-retinal. In this review, we discuss the use of homology modeling to investigate the structures and functions of GPCRs. We illustrate the use of homology modeling with a particular emphasis on ligand and drug binding sites in the Family C subfamily of GPCRs.
Keywords: Homology modeling, ligand-receptor interaction, ligand docking, mGluR, Family C GPCRs, cysteine-rich domain, allosteric modulato
Current Computer-Aided Drug Design
Title: An Introduction to Molecular Modeling of G-Protein Coupled Receptors
Volume: 2 Issue: 3
Author(s): Minghua Wang, Lakshmi P. Kotra and David R. Hampson
Affiliation:
Keywords: Homology modeling, ligand-receptor interaction, ligand docking, mGluR, Family C GPCRs, cysteine-rich domain, allosteric modulato
Abstract: G-protein coupled receptors (GPCRs) are the largest single family of signaling molecules in mammals and represent approximately 2-3% of all genes in the human genome. Estimates of the total number of GPCR genes in the human genome range from about 750 to 1000. GPCRs mediate signaling by a wide variety of ligands including amino acids, ions, biogenic amines, peptides, glycoproteins, light, pheromones, and odorants. There are presently only a handful of GPCRs whose structures have been elucidated. Of these, the mGluR1 subtype of metabotropic glutamate receptor (mGluR) and rhodopsin are the most widely used in modeling GPCRs. In the case of mGluR1, the three-dimensional structure of the extracellular ligand binding domain of the molecule has been solved, while the crystallographic data for rhodopsin encompasses the whole protein in the ground state with bound 11-cis-retinal. In this review, we discuss the use of homology modeling to investigate the structures and functions of GPCRs. We illustrate the use of homology modeling with a particular emphasis on ligand and drug binding sites in the Family C subfamily of GPCRs.
Export Options
About this article
Cite this article as:
Wang Minghua, Kotra P. Lakshmi and Hampson R. David, An Introduction to Molecular Modeling of G-Protein Coupled Receptors, Current Computer-Aided Drug Design 2006; 2 (3) . https://dx.doi.org/10.2174/157340906778226409
DOI https://dx.doi.org/10.2174/157340906778226409 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Severe Preeclampsia
Current Women`s Health Reviews Involvement of microRNA-146a in the Inflammatory Response of S tatus Epilepticus Rats
CNS & Neurological Disorders - Drug Targets The Endocannabinoid System May Modulate Sleep Disorders in Aging
Current Neuropharmacology Somatic Genome Variations in Health and Disease
Current Genomics ORO-Dental Manifestations in West Syndrome
Current Topics in Medicinal Chemistry Clinical Features of Scleroderma-Like Disorders: A Challenge for the Rheumatologist
Current Rheumatology Reviews Aptiom (Eslicarbazepine Acetate) as a Dual Inhibitor of β-Secretase and Voltage-Gated Sodium Channel: Advancement in Alzheimer's Disease-Epilepsy Linkage via an Enzoinformatics Study
CNS & Neurological Disorders - Drug Targets Tryptamine Induces Axonopathy and Mitochondriopathy Mimicking Neurodegenerative Diseases via Tryptophanyl-tRNA Deficiency
Current Alzheimer Research Pharmacological Strategies for Neuroprotection in Traumatic Brain Injury
Mini-Reviews in Medicinal Chemistry Mitogenomics: Recognizing the Significance of Mitochondrial Genomic Variation for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets Triheptanoin Supplementation to Ketogenic Diet Curbs Cognitive Impairment in APP/PS1 Mice Used as a Model of Familial Alzheimer’s Disease
Current Alzheimer Research Phytochemicals as Prototypes for Pharmaceutical Leads Towards Drug Development Against Diabetic Cardiomyopathy
Current Pharmaceutical Design Blockers of Voltage-Gated Sodium Channels for the Treatment of Central Nervous System Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Pharmacological Investigation and Unraveling Mechanism of Action of Jasminum sambac Flowers for Predicated Treatment of Alzheimer’s Disease
Current Nutrition & Food Science Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
Current Pharmaceutical Design Recent Developments in Anxiety Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Bioactivity Guided Isolation of Quercetin as Anxiolytic Compound from Elaeocarpus ganitrus Beads
The Natural Products Journal Hybrid Imaging: Conclusions and Perspectives
Current Medical Imaging Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry